Munich, 25 August 2023 - The Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM) announced today the launch of Vax2Muc. Over the next 5 years, Vax2Muc will receive almost 8.5 million Euro from Horizon Europe to develop next generation vaccines against gastrointestinal mucosal pathogens.